Company intelligence / Profile preview

Radiance Therapeutics

Tucson, Arizona, United Statesradiancetherapeutics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Radiance Therapeutics has developed a next-generation ophthalmic beta therapy applicator for treating eye conditions. The company has secured US FDA 510(k) regulatory clearance and holds multiple patents in the field of ophthalmology. Their technology aims to improve outcomes in the treatment of diseases such as glaucoma by delivering targeted beta radiation to affected tissues.

Therapeutic areas: Ophthalmology
Modalities: Device (ophthalmic beta therapy applicator)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

MINIject

Commercial

Indications: Open-angle glaucoma

Beyond the preview

Go deeper on Radiance Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Radiance Therapeutics.

Explore the full profile